Anti-p19 INK4d antibody [RP23040113]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Multiclonal p19 INK4d antibody. Suitable for WB, IP and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human Cyclin-dependent kinase 4 inhibitor D.
View Alternative Names
Cyclin-dependent kinase 4 inhibitor D, p19-INK4d, CDKN2D
- IP
Supplier Data
Immunoprecipitation - Anti-p19 INK4d antibody [RP23040113] (AB308000)
P19INK4D was immunoprecipitated using 2 µg of ab30800 from lysate of HeLa cells treated with Trichostatin A (2 uM/24 hours) (Lane 3). Normal Rabbit IgG was used as a negative IP control (Lane 2). 10% input represents the cell extract used for immunoprecipitation (Lane 1). Western blot analysis was performed using ab307800 and Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1 : 2500 dilution. Chemiluminescent detection was performed (ECL).
All lanes:
Immunoprecipitation - Anti-p19 INK4d antibody [RP23040113] (ab308000) at 2 µg
Lane 1:
HeLa cell lysate
Lane 2:
HeLa cell lysate with normal rabbit IgG
Lane 3:
HeLa cells lysate treated with Trichostatin A
Secondary
All lanes:
HRP-conjugated Goat anti-Rabbit IgG (H+L) Secondary Antibody at 1/2500 dilution
Observed band size: 18 kDa
true
- WB
Supplier Data
Western blot - Anti-p19 INK4d antibody [RP23040113] (AB308000)
Western blot analysis was performed on whole cell extracts (30 µg lysate) of HEK- 293 (Lane1), HEK- 293 treated with Trichostatin A, (Lane 2), HeLa (Lane 3), HeLa treated with Trichostatin A (Lane 4), HCT 116 (Lane 5), HCT 116 treated with Trichostatin A (Lane 6) (2µM/24hrs). The blots were probed with ab308000 at 0.5-1 µg/mL and detected by chemiluminescence using Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1 : 2500 dilution. A clear 18 kDa band corresponding to P19INK4D was observed across cell lines tested. Known quantity of protein samples were electrophoresed using a 4-12% Bis-Tris gel, electrophoresis system and pre-stained protein standard. Resolved proteins were then transferred onto a nitrocellulose membrane. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5% skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western blotting Substrate
All lanes:
Western blot - Anti-p19 INK4d antibody [RP23040113] (ab308000) at 0.5 µg/mL
Lane 1:
Untreated HEK- 293 at 30 µg
Lane 2:
HEK- 293 treated with Trichostatin A at 30 µg
Lane 3:
Untreated HeLa at 30 µg
Lane 4:
HeLa treated with Trichostatin A at 30 µg
Lane 5:
HCT 116 at 30 µg
Lane 6:
HCT 116 treated with Trichostatin A at 30 µg
Secondary
All lanes:
HRP-conjugated Goat anti-Rabbit IgG (H+L) Secondary Antibody at 1/2500 dilution
Observed band size: 18 kDa
true
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The p19 protein exerts its effects by tightly binding to CDK4 and CDK6 forming a complex that impedes their kinase activity. This interaction results in the prevention of the phosphorylation of the retinoblastoma protein (pRb) a critical step required for cell cycle progression from G1 to S phase. In doing so p19 INK4d maintains cellular growth control and prevents the transition into unchecked cell division. The regulation of pRb is vital for the prevention of cancerous growth as phosphorylated pRb releases E2F transcription factors that drive S phase entry and DNA synthesis.
Pathways
The activity of p19 INK4d influences the retinoblastoma (Rb) pathway one of the major pathways governing cell cycle control. The Rb pathway regulates the transcriptional repression of E2F target genes associated with cell cycle progression. Besides its interaction with Rb p19 INK4d is also connected with the p53 pathway which oversees cellular responses to DNA damage and stress. This links p19 INK4d indirectly to proteins like the MDM2 and p21 where these pathways intersect to coordinate cell cycle arrest mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com